Jennifer Gunter
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jennifer Gunter has a total of 1 co-authors. Here are the top co-authors by number of shared publications:
Loren Golitz
1 shared publication
Latest Publications
- 1 July 2005
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 9 (3) , 176-180
Topical Misoprostol Therapy for Plasma Cell Vulvitis: A Case Series
To present the first reported case series of plasma cell vulvitis successfully treated with topical misoprostol. Three women with vulvar pain and lesions secondary to plasma cell vulvitis refractory to conventional therapy were treated with topical misoprostol compounded in white petrolatum. All three patients had resolution of pain and lesions within 6 weeks of starting topical misoprostol. All patients tolerated the 0.01% concentration; however, local side effects were seen with the higher 0.02% concentration. Plasma cell vulvitis is a rare and painful vulvar disorder that it is often refractory to therapy. All three patients in this case series were successfully treated with topical misoprostol. The immunosuppressive effects of misoprostol are hypothesized to be the mechanisms of action of this novel therapy for plasma cell vulvitis.
- 1 July 2005
- Published by Wolters Kluwer Health in Journal of Lower Genital Tract Disease
- Vol. 9 (3) , 176-180
Topical Misoprostol Therapy for Plasma Cell Vulvitis: A Case Series
To present the first reported case series of plasma cell vulvitis successfully treated with topical misoprostol. Three women with vulvar pain and lesions secondary to plasma cell vulvitis refractory to conventional therapy were treated with topical misoprostol compounded in white petrolatum. All three patients had resolution of pain and lesions within 6 weeks of starting topical misoprostol. All patients tolerated the 0.01% concentration; however, local side effects were seen with the higher 0.02% concentration. Plasma cell vulvitis is a rare and painful vulvar disorder that it is often refractory to therapy. All three patients in this case series were successfully treated with topical misoprostol. The immunosuppressive effects of misoprostol are hypothesized to be the mechanisms of action of this novel therapy for plasma cell vulvitis.
- 1 September 2003
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 189 (3) , S3-S11
Genital and perianal warts: new treatment opportunities for human papillomavirus infection
- 1 September 2003
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 189 (3) , S3-S11
Genital and perianal warts: new treatment opportunities for human papillomavirus infection
- 1 September 2003
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 58 (9) , 615-623
Chronic Pelvic Pain: An Integrated Approach to Diagnosis and Treatment
Chronic pelvic pain affects upward of 15% of women and is a frustrating condition for both patients and physicians. Chronic pelvic pain is not a disease, but a syndrome that results from a complex interaction between neurologic, musculoskeletal, and endocrine systems that is further influenced by behavioral and psychologic factors. Traditional approaches to this disorder have been surgical, although long-term success rates have been disappointing. Placebo response to surgery is common, and many conditions that contribute to the pain cannot be identified or treated with a surgical approach. Many patients will require a combination of both pharmacologic and nonpharmacologic treatments in addition to various types of invasive procedures. It is now recognized that many disorders contribute to the chronic pelvic pain symptom complex; thus, an integrated multidisciplinary approach to diagnosis and treatment is essential to achieve the greatest success. Obstetricians & Gynecologists, Family Physicians. After completion of this article, the reader will be able to describe the pathophysiology of chronic pelvic pain, to outline the evaluation of a patient with chronic pelvic pain, and to explain the treatment options for patients with chronic pelvic pain.
- 1 September 2003
- Published by Wolters Kluwer Health in Obstetrical & Gynecological Survey
- Vol. 58 (9) , 615-623
Chronic Pelvic Pain: An Integrated Approach to Diagnosis and Treatment
Chronic pelvic pain affects upward of 15% of women and is a frustrating condition for both patients and physicians. Chronic pelvic pain is not a disease, but a syndrome that results from a complex interaction between neurologic, musculoskeletal, and endocrine systems that is further influenced by behavioral and psychologic factors. Traditional approaches to this disorder have been surgical, although long-term success rates have been disappointing. Placebo response to surgery is common, and many conditions that contribute to the pain cannot be identified or treated with a surgical approach. Many patients will require a combination of both pharmacologic and nonpharmacologic treatments in addition to various types of invasive procedures. It is now recognized that many disorders contribute to the chronic pelvic pain symptom complex; thus, an integrated multidisciplinary approach to diagnosis and treatment is essential to achieve the greatest success. Obstetricians & Gynecologists, Family Physicians. After completion of this article, the reader will be able to describe the pathophysiology of chronic pelvic pain, to outline the evaluation of a patient with chronic pelvic pain, and to explain the treatment options for patients with chronic pelvic pain.